THE IMPORTANCE OF MOLECULAR AND CYTOGENETIC MARKERS IN THE PROGNOSTIC OF MYELODYSPLASTIC SYNDROMES
Nicorescu Iuliana-Maria 11 Hematology, Neolife Medical Center, Bucharest, Romania Abstract Myelodysplastic syndromes represent clonal diseases of hematopoietic stem cells that occur predominantly